Skip to main content

Share story

Policy

U.S. District Court vacates FTC changes to Hart-Scott-Rodino premerger notification rules

U.S. District Court vacates FTC changes to Hart-Scott-Rodino premerger notification rules Image: Primary
The U.S. District Court for the Eastern District of Texas on Feb. 12 vacated a final rule by the Federal Trade Commission that changed premerger notification rules, form and instructions under the Hart-Scott-Rodino Antitrust Improvements Act. The rule had increased reporting requirements on the HSR form. The final rule was challenged by the U.S. Chamber of Commerce in 2024. Judge Jeremy D. Kernodle wrote in his opinion that the Final Rule exceeds the FTC's statutory authority because the agency has not shown that the Rule's claimed benefits will reasonably outweigh its significant and widespread costs. Though the FTC asserts that the Rule will detect illegal mergers and save agency resources, the FTC fails to substantiate these assertions. The Final Rule is therefore not necessary and appropriate, and the statute does not authorize the FTC to promulgate the Final Rule. The AHA filed an amicus brief in the case last year, explaining that the changes made by the FTC under the HSR Act were unnecessary and unlawful. Key aspects of the decision, including the court's rejection of the FTC's reliance on a study regarding hospital mergers, were based on arguments made in the AHA's amicus brief.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from AHA and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.